HeyJaredManjeera Gowravaram
- Indexed articles, last 90 days
- 3
- Latest publication
- Sep 10, 2026
- Outlet visibility, for thehindu.com
- Top 5K sites
- Earliest in this view
- Jul 7, 2026
Latest articles
How scientists are using menstrual blood to treat osteoarthritis (opens the original)
Read excerpt
For most of history, menstrual blood has been dismissed as biological waste. But emerging research is now recasting this material as a goldmine for non-invasive diagnostics and regenerative medicine. Its potential applications are surprisingly broad, ranging from innovative cervical cancer screenings to advanced cartilage repair. Much like saliva or blood plasma, menstrual fluid is rich with biological information. It is packed with immune cells, endometrial tissue, proteins, and genetic fragmen
How protein biosensors can shrink the timeline of medical emergencies (opens the original)
Read excerpt
A patient arrives at a hospital showing signs of sepsis, a deadly condition where the immune system attacks its own body after an infection. Sepsis kills 11 million people every year. Doctors must treat it within hours to save lives, but standard blood tests take up to 48 hours for results. Last year, researchers reported a sensor platform capable of detecting multiple immune proteins linked to sepsis from a blood sample in real time. It was also compact enough for bedside use. The device was a
Why FDA approval for vepdegestrant is a major shift in cancer therapy (opens the original)
Read excerpt
On May 1, the U.S. Food and Drug Administration (FDA) approved the drug vepdegestrant for patients with ESR1-mutated, ER-positive, and HER2-negative advanced breast cancer. It is the world’s first therapy that the FDA — whose lead many drug regulators worldwide follow — has approved that is based on PROTAC technology. The approval paves the way for drugs designed to remove harmful proteins from cells, rather than simply block them. This is an advance because PROTACs can sidestep the barriers to
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5K sites
For thehindu.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.